Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets OTCPK - Delayed Quote USD

Holdco Nuvo Group D.G Ltd (NUVOQ)

Compare
0.0010
0.0000
(0.00%)
At close: April 17 at 4:00:00 PM EDT
Loading Chart for NUVOQ
  • Previous Close 0.0000
  • Open 0.0009
  • Bid 0.0009 x --
  • Ask 0.0038 x --
  • Day's Range 0.0009 - 0.0009
  • 52 Week Range 0.0009 - 8.5600
  • Volume 58,691
  • Avg. Volume 2,406
  • Market Cap (intraday) 33,261
  • Beta (5Y Monthly) -0.16
  • PE Ratio (TTM) --
  • EPS (TTM) -1.0100
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Holdco Nuvo Group D.G Ltd engages in the research, development, and marketing of medical devices for pregnancy monitoring in Israel, the United States, and internationally. It provides INVU platform, a remote pregnancy monitoring platform that provides expectant mothers with a self -administered wireless sensory band, which enables them and their obstetricians to monitor maternal and fetal heart rate, and maternal uterine activity at home and in the clinic from the 32nd week of pregnancy until the beginning of labor. The company's INVU platform includes a wireless sensory band with multi-modality technology to capture signals to enable the INVU platform; and a cloud computing environment that processes and analyzes data and transmits personalized reports on maternal and fetal health metrics to the expectant mother and her obstetrician through digital visualization tools. It has a collaboration with Royal Philips and Charité – Universitätsmedizin Berlin. The company was formerly known as Nuvo Group Ltd. and changed its name to Holdco Nuvo Group D.G Ltd in May 2024. Holdco Nuvo Group D.G Ltd incorporated in 2006 and is headquartered in Tel Aviv, Israel. On August 22, 2024, Holdco Nuvo Group D.G Ltd filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

www.nuvocares.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NUVOQ

View More

Performance Overview: NUVOQ

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NUVOQ
66.67%
S&P 500 (^GSPC)
10.18%

1-Year Return

NUVOQ
99.99%
S&P 500 (^GSPC)
5.19%

3-Year Return

NUVOQ
99.99%
S&P 500 (^GSPC)
20.26%

5-Year Return

NUVOQ
99.99%
S&P 500 (^GSPC)
83.77%

Compare To: NUVOQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NUVOQ

View More

Valuation Measures

Annual
As of 4/17/2025
  • Market Cap

    29.93k

  • Enterprise Value

    11.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    62.80

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -37.76M

  • Diluted EPS (ttm)

    -1.0100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    407k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: NUVOQ

View More

Company Insights: NUVOQ

Research Reports: NUVOQ

View More